The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9098|112|6|597-602

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.112, Iss.6, 2015-11, pp. : 597-602

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumor heterogeneity in esophageal cancer

By  

DISEASES OF THE ESOPHAGUS (ELECTRONIC), Vol. 28, Iss. 2, 2015-02 ,pp. : 172-179

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influence of tumor response and treatment schedule on the distribution of tumor recurrence in esophageal cancer patients treated with neoadjuvant chemoradiotherapy

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 116, Iss. 8, 2017-12 ,pp. : 1096-1102

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is the Standardized Uptake Value of FDG-PET/CT Predictive of Pathological Complete Response in Locally Advanced Rectal Cancer Treated with Capecitabine-Based Neoadjuvant Chemoradiation?

By  

Oncology, Vol. 84, Iss. 4, 2013-01 ,pp. : 191-199

Karger

Access to resources Recommend Favorite

Regional lymph node status after neoadjuvant chemoradiation of rectal cancer producing a complete or near complete rectal wall response

By  

COLORECTAL DISEASE, Vol. 17, Iss. 7, 2015-07 ,pp. : 595-599

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Value of Metastatic Nodal Volume and Lymph Node Ratio in Patients with Cervical Lymph Node Metastases from an Unknown Primary Tumor

By  

Oncology, Vol. 86, Iss. 3, 2014-04 ,pp. : 170-176

Karger

Access to resources Recommend Favorite